Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Normal Saline	30
Overall Study	STARTED	Sufentanil	30
Overall Study	STARTED	Dexmedetomidine	30
Overall Study	STARTED	Nalmefene	30
Overall Study	STARTED	Dexmedetomidine-Nalmefene	30
Overall Study	COMPLETED	Normal Saline	27
Overall Study	COMPLETED	Sufentanil	27
Overall Study	COMPLETED	Dexmedetomidine	27
Overall Study	COMPLETED	Nalmefene	27
Overall Study	COMPLETED	Dexmedetomidine-Nalmefene	27
Overall Study	NOT COMPLETED	Normal Saline	3
Overall Study	NOT COMPLETED	Sufentanil	3
Overall Study	NOT COMPLETED	Dexmedetomidine	3
Overall Study	NOT COMPLETED	Nalmefene	3
Overall Study	NOT COMPLETED	Dexmedetomidine-Nalmefene	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03096730/flow